Rovi

Pozuelo De Alarcon, Spain Founded: 1946 • Age: 80 yrs
Pharmaceutical products manufacturer and CDMO services provider
Annual revenue $793.5M Latest available
Total funding - 1 rounds
Employees 2200 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Rovi

Rovi is a company based in Pozuelo De Alarcon (Spain) founded in 1946. The company has 2,200 employees as of December 31, 2024.

  • Headquarter Pozuelo De Alarcon, Spain
  • Employees 2200 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Laboratorios Farmaceuticos Rovi, S.A.
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $793.46 M (USD)
    -7.93
    as on Dec 31, 2024
  • Net Profit
    $142.2 M (USD)
    -19.64
    as on Dec 31, 2024
  • EBITDA
    $214.76 M (USD)
    -15.21
    as on Dec 31, 2024
  • Latest Funding Round
    $92.85 M (USD), Post-IPO

    Sep 01, 2018

  • Investors
    Not available
  • Employee Count
    2200

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Rovi

Rovi is a publicly listed company on the BME with ticker symbol ROVI in Spain, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: BME · Ticker: ROVI · Sector: Health technology · Spain

Funding Insights of Rovi

Investments & Acquisitions by Rovi

Investments
Premium access

Investment portfolio details for Rovi

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Rovi

Premium access

Detailed financials for Rovi

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Rovi Comparisons

Rovi Primary company
Description
Pharmaceutical products manufacturer and CDMO services provi...
Location
Pozuelo De Alarcon, Spain
Founded Year
1946
Annual Revenue
$793.46 M (USD)
Net Profit
$142.2 M (USD)
EBITDA
$214.76 M (USD)
Employees
2,200
As of 2024
Premium access

Peer comparison for Rovi

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Rovi

Premium access

Detailed competitors of Rovi

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Rovi

Premium access

Complete news archive for Rovi

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rovi

Rovi was founded in 1946 and raised its 1st funding round 72 years after it was founded.

Rovi is headquartered in Pozuelo De Alarcon, Spain. It is registered at Pozuelo De Alarcon, Madrid, Spain.

Juan Encina is the current CEO of Rovi.

As of Dec 31, 2024, the latest employee count at Rovi is 2,200.

Annual revenue of Rovi is $793.46M as on Dec 31, 2024.

Rovi was founded in 1946 as a pharmaceutical manufacturer and CDMO services provider. Operations include production of prescription drugs and hospital supplies, alongside contract services for prefilled syringes and oral solid forms. Focus is placed on biosimilars and low-molecular-weight heparin. Investments are made in research and development to support growth. A portfolio of own and licensed products is maintained across various categories.

Yes, Rovi is publicly traded on BME under the ticker symbol ROVI.

The ticker symbol of Rovi is ROVI on BME.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available